Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


01.01.2018

1 AIDS Care
1 Am J Med Sci
1 Am J Obstet Gynecol
1 Am J Reprod Immunol
1 Am J Surg Pathol
1 Ann Agric Environ Med
1 Ann Oncol
1 Arch Gynecol Obstet
1 Asia Pac J Clin Oncol
1 Asian Pac J Cancer Prev
2 Biomed Pharmacother
1 BMJ Open
2 Brachytherapy
1 Cad Saude Publica
1 Cancer
1 Cancer Manag Res
1 Cell Oncol (Dordr)
1 Cell Physiol Biochem
1 Clin Obstet Gynecol
3 Eur Rev Med Pharmacol Sci
1 EXCLI J
2 Exp Ther Med
1 Gene
1 Gene Ther
1 Georgian Med News
2 Gynecol Oncol
1 Gynecol Oncol Res Pract
1 IEEE Trans Med Imaging
1 Int J Cancer
1 Int J Mol Sci
2 Int J Radiat Oncol Biol Phys
1 Int J Surg
1 J Cell Biochem
1 J Cell Physiol
1 J Infect Dis
2 J Low Genit Tract Dis
1 J Nat Prod
1 Lancet Public Health
1 Magy Onkol
1 Mol Carcinog
1 Obstet Gynecol Clin North Am
2 Oncol Lett
4 Oncotarget
1 Papillomavirus Res
3 PLoS One
1 Prev Med
2 Psychooncology
1 Radiat Oncol
1 Radiat Oncol J
1 Rev Epidemiol Sante Publique
1 Sensors (Basel)
1 Signal Transduct Target Ther
1 Soc Sci Med
1 Tidsskr Nor Laegeforen
4 Virus Res
1 Viruses


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS Care

  1. GANTA V, Moonie S, Patel D, Hunt AT, et al
    Timely reminder interventions to improve annual Papanicolaou (Pap) smear rates among HIV-infected women in an outpatient center of southern Nevada: a short report.
    AIDS Care. 2017;29:1099-1101.
    PubMed     Text format     Abstract available


    Am J Med Sci

  2. PIZZO K, Arnold C, Wispelwey B
    Actinomyces neuii Causing Vertebral Osteomyelitis.
    Am J Med Sci. 2017;353:407-410.
    PubMed     Text format    


    Am J Obstet Gynecol

  3. BECERRA-CULQUI TA, Lonky NM, Chen Q, Chao CR, et al
    Patterns and correlates of cervical cancer screening initiation in a large integrated healthcare system.
    Am J Obstet Gynecol. 2017 Dec 22. pii: S0002-9378(17)32708.
    PubMed     Text format     Abstract available


    Am J Reprod Immunol

  4. ZHANG Y, Jin LP
    Effects of TSLP on obstetrical and gynecological diseases.
    Am J Reprod Immunol. 2017;77.
    PubMed     Text format     Abstract available


    Am J Surg Pathol

  5. SHAIN AF, Kwok S, Folkins AK, Kong CS, et al
    Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
    Am J Surg Pathol. 2018;42:69-75.
    PubMed     Text format     Abstract available


    Ann Agric Environ Med

  6. MAZDZIARZ A, Wygledowski J, Osuch B, Jagielska B, et al
    New directions in cervical cancer prophylaxis worldwide and in Poland - Case study of the Polish rural female population.
    Ann Agric Environ Med. 2017;24:592-595.
    PubMed     Text format     Abstract available


    Ann Oncol

  7. THAKER PH, Salani R, Brady WE, Lankes HA, et al
    A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852).
    Ann Oncol. 2017;28:505-511.
    PubMed     Text format     Abstract available


    Arch Gynecol Obstet

  8. ASHRAFI-ASGARABAD A, Safiri S
    Therapy-free interval has prognostic value in patients with recurrent cervical cancer treated with chemotherapy following definitive concurrent chemoradiotherapy: methodological issues.
    Arch Gynecol Obstet. 2017 Dec 21. pii: 10.1007/s00404-017-4629.
    PubMed     Text format    


    Asia Pac J Clin Oncol

  9. EL SAYED ME, Bahadur YA, Hassouna AH, Fawzy EE, et al
    Outcome of cervix uteri cancer patients: Clinical treatment results and toxicity profile in a retrospective study from Saudi Arabia.
    Asia Pac J Clin Oncol. 2017;13:e364-e372.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  10. AL-HAMMADI FA, Al-Tahri F, Al-Ali A, Nair SC, et al
    Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates
    Asian Pac J Cancer Prev. 2017;18:3379-3387.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  11. WANG D, Li Q, Li Y, Wang H, et al
    The role of MCM5 expression in cervical cancer: Correlation with progression and prognosis.
    Biomed Pharmacother. 2017;98:165-172.
    PubMed     Text format     Abstract available

  12. GUO F, Chen YZ, Li L, Chen C, et al
    Long non-coding RNA XLOC_008466 acts as an oncogenic molecular in cervical cancer tumorigenesis.
    Biomed Pharmacother. 2017;98:88-94.
    PubMed     Text format     Abstract available


    BMJ Open

  13. GOTTVALL M, Stenhammar C, Grandahl M
    Parents' views of including young boys in the Swedish national school-based HPV vaccination programme: a qualitative study.
    BMJ Open. 2017;7:e014255.
    PubMed     Text format     Abstract available


    Brachytherapy

  14. JACOB D, Lamberto M, DeSouza Lawrence L, Mourtada F, et al
    Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
    Brachytherapy. 2017;16:624-629.
    PubMed     Text format     Abstract available

  15. UMEZAWA R, Murakami N, Nakamura S, Wakita A, et al
    Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.
    Brachytherapy. 2017 Dec 21. pii: S1538-4721(17)30532.
    PubMed     Text format     Abstract available


    Cad Saude Publica

  16. RAFAEL RMR, Moura ATMS
    Severe intimate partner physical violence as a risk factor for inadequate cervical cancer screening.
    Cad Saude Publica. 2017;33:e00074216.
    PubMed     Text format     Abstract available


    Cancer

  17. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Text format     Abstract available


    Cancer Manag Res

  18. WU SG, Zhang WW, He ZY, Sun JY, et al
    Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer.
    Cancer Manag Res. 2017;9:813-819.
    PubMed     Text format     Abstract available


    Cell Oncol (Dordr)

  19. WASIM L, Chopra M
    Synergistic anticancer effect of panobinostat and topoisomerase inhibitors through ROS generation and intrinsic apoptotic pathway induction in cervical cancer cells.
    Cell Oncol (Dordr). 2017 Dec 19. pii: 10.1007/s13402-017-0366.
    PubMed     Text format     Abstract available


    Cell Physiol Biochem

  20. ZHEN S, Li X
    Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer.
    Cell Physiol Biochem. 2017;44:2455-2466.
    PubMed     Text format     Abstract available


    Clin Obstet Gynecol

  21. GUIDO R
    Cervical Cancer Screening.
    Clin Obstet Gynecol. 2017 Dec 15. doi: 10.1097/GRF.0000000000000336.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  22. YE GL, Du DL, Jin LJ, Wang LL, et al
    Sensitization of TRAIL-resistant cervical cancer cells through combination of TRAIL and fucoxanthin treatments.
    Eur Rev Med Pharmacol Sci. 2017;21:5594-5601.
    PubMed     Text format     Abstract available

  23. ZHAO Y, Liu X, Lu YX
    MicroRNA-143 regulates the proliferation and apoptosis of cervical cancer cells by targeting HIF-1alpha.
    Eur Rev Med Pharmacol Sci. 2017;21:5580-5586.
    PubMed     Text format     Abstract available

  24. WEI H, Zhang JJ, Tang QL
    MiR-638 inhibits cervical cancer metastasis through Wnt/beta-catenin signaling pathway and correlates with prognosis of cervical cancer patients.
    Eur Rev Med Pharmacol Sci. 2017;21:5587-5593.
    PubMed     Text format     Abstract available


    EXCLI J

  25. WEI Y, Dong J, Li F, Wei Z, et al
    Knockdown of SLC39A7 suppresses cell proliferation, migration and invasion in cervical cancer.
    EXCLI J. 2017;16:1165-1176.
    PubMed     Text format     Abstract available


    Exp Ther Med

  26. ZHAI L, Li Y, Lan X, Ai L, et al
    MicroRNA-10a-5p suppresses cancer proliferation and division in human cervical cancer by targeting BDNF.
    Exp Ther Med. 2017;14:6147-6151.
    PubMed     Text format     Abstract available

  27. GONG P, Hu C, Zhou X, Wang R, et al
    TAT-mediated si-hWAPL inhibits the invasion and metastasis of cervical cancer stem cells.
    Exp Ther Med. 2017;14:5452-5458.
    PubMed     Text format     Abstract available


    Gene

  28. LIU J, Ni S
    Association between genetic polymorphisms in the promoters of let-7 and risk of cervical squamous cell carcinoma.
    Gene. 2018;642:256-260.
    PubMed     Text format     Abstract available


    Gene Ther

  29. SUN Y, Peng S, Yang A, Farmer E, et al
    Coinjection of IL2 DNA enhances E7-specific antitumor immunity elicited by intravaginal therapeutic HPV DNA vaccination with electroporation.
    Gene Ther. 2017;24:408-415.
    PubMed     Text format     Abstract available


    Georgian Med News

  30. LYTVYNENKO M, Bocharova T, Zhelezniakova N, Narbutova T, et al
    CERVICAL TRANSFORMATION IN ALCOHOL ABUSE PATIENTS.
    Georgian Med News. 2017;:12-17.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  31. XIANG L, Jiang W, Ye S, He T, et al
    ERBB2 mutation: A promising target in non-squamous cervical cancer.
    Gynecol Oncol. 2017 Dec 23. pii: S0090-8258(17)31614.
    PubMed     Text format     Abstract available

  32. LEE J, Lin JB, Chang CL, Sun FJ, et al
    Impact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodes.
    Gynecol Oncol. 2017 Dec 18. pii: S0090-8258(17)31550.
    PubMed     Text format     Abstract available


    Gynecol Oncol Res Pract

  33. ERKU DA, Netere AK, Mersha AG, Abebe SA, et al
    Comprehensive knowledge and uptake of cervical cancer screening is low among women living with HIV/AIDS in Northwest Ethiopia.
    Gynecol Oncol Res Pract. 2017;4:20.
    PubMed     Text format     Abstract available


    IEEE Trans Med Imaging

  34. SONG Y, Tan EL, Jiang X, Cheng JZ, et al
    Accurate Cervical Cell Segmentation from Overlapping Clumps in Pap Smear Images.
    IEEE Trans Med Imaging. 2017;36:288-300.
    PubMed     Text format     Abstract available


    Int J Cancer

  35. MANCINI S, Ravaioli A, Giuliani O, Vattiato R, et al
    Incidence and survival trends of cervical adenocarcinoma in Italy: Cytology screening has become more effective in downstaging the disease but not in detecting its precursors.
    Int J Cancer. 2017;140:247-248.
    PubMed     Text format    


    Int J Mol Sci

  36. WU MH, Lin CL, Chiou HL, Yang SF, et al
    Praeruptorin A Inhibits Human Cervical Cancer Cell Growth and Invasion by Suppressing MMP-2 Expression and ERK1/2 Signaling.
    Int J Mol Sci. 2017;19.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  37. MAHANTSHETTY U, Krishnatry R, Hande V, Jamema S, et al
    Magnetic Resonance Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: An Experience From a Tertiary Cancer Center in a Low and Middle Income Countries Setting.
    Int J Radiat Oncol Biol Phys. 2017;99:608-617.
    PubMed     Text format     Abstract available

  38. GLASER S, Mahantshetty U, Lee L, Klopp A, et al
    Genomics and 3-Dimensional Brachytherapy for Cervical Cancer: Significant Steps Forward.
    Int J Radiat Oncol Biol Phys. 2017;99:505-509.
    PubMed     Text format    


    Int J Surg

  39. ZHOU J, Wu SG, Sun JY, Li FY, et al
    The effect of local treatment modalities in patients with early-stage adenocarcinoma of the uterine cervix: A population-based analysis.
    Int J Surg. 2017;41:16-22.
    PubMed     Text format     Abstract available


    J Cell Biochem

  40. EID W, Abdel-Rehim W
    Neferine Enhances the Antitumor Effect of Mitomycin-C in Hela Cells Through the Activation of p38-MAPK Pathway.
    J Cell Biochem. 2017;118:3472-3479.
    PubMed     Text format     Abstract available


    J Cell Physiol

  41. REN CC, Yang L, Liu L, Chen YN, et al
    Effects of shRNA-mediated Silencing of PSMA7 on Cell Proliferation and Vascular Endothelial Growth Factor Expression via the Ubiquitin-Proteasome Pathway in Cervical Cancer.
    J Cell Physiol. 2017 Dec 16. doi: 10.1002/jcp.26408.
    PubMed     Text format     Abstract available


    J Infect Dis

  42. DROLET M, Laprise JF, Brotherton JML, Donovan B, et al
    The impact of human papillomavirus catch-up vaccination in Australia: Implications for introduction of multiple age cohort vaccination and post-vaccination data interpretation.
    J Infect Dis. 2017 Sep 12. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Low Genit Tract Dis

  43. HAMMER A, Hee L, Blaakaer J, Gravitt P, et al
    Temporal Patterns of Cervical Cancer Screening Among Danish Women 55 Years and Older Diagnosed With Cervical Cancer.
    J Low Genit Tract Dis. 2018;22:1-7.
    PubMed     Text format     Abstract available

  44. TEOH D, Shaikh R, Vogel RI, Zoellner T, et al
    A Cross-Sectional Review of Cervical Cancer Messages on Twitter During Cervical Cancer Awareness Month.
    J Low Genit Tract Dis. 2018;22:8-12.
    PubMed     Text format     Abstract available


    J Nat Prod

  45. KRUAKAEW S, Seeka C, Lhinhatrakool T, Thongnest S, et al
    Cytotoxic Cardiac Glycoside Constituents of Vallaris glabra Leaves.
    J Nat Prod. 2017;80:2987-2996.
    PubMed     Text format     Abstract available


    Lancet Public Health

  46. RONCO G, Baussano I
    Causal system modelling of cervical cancer screening.
    Lancet Public Health. 2017;2:e61-e62.
    PubMed     Text format    


    Magy Onkol

  47. VAJDA R, Arvane Egri C, Kovacs A, Budai A, et al
    [Quality and performance indicators of the pilot program for cervical cancer screening by health visitors].
    Magy Onkol. 2017;61:361-367.
    PubMed     Text format     Abstract available


    Mol Carcinog

  48. LIU M, An J, Huang M, Wang L, et al
    MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas.
    Mol Carcinog. 2018;57:32-43.
    PubMed     Text format     Abstract available


    Obstet Gynecol Clin North Am

  49. BURTON ER, Sorosky JI
    Recognition and Therapeutic Options for Malignancy of the Cervix and Uterus.
    Obstet Gynecol Clin North Am. 2017;44:195-206.
    PubMed     Text format     Abstract available


    Oncol Lett

  50. ZHOU WJ, Yang HL, Chang KK, Meng Y, et al
    Human thymic stromal lymphopoietin promotes the proliferation and invasion of cervical cancer cells by downregulating microRNA-132 expression.
    Oncol Lett. 2017;14:7910-7916.
    PubMed     Text format     Abstract available

  51. SEN P, Ganguly P, Ganguly N
    Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer.
    Oncol Lett. 2018;15:11-22.
    PubMed     Text format     Abstract available


    Oncotarget

  52. WANG W, Meng Q, Hou X, Lian X, et al
    Efficacy and toxicity of image-guided intensity-modulated radiation therapy combined with dose-escalated brachytherapy for stage IIB cervical cancer.
    Oncotarget. 2017;8:102965-102973.
    PubMed     Text format     Abstract available

  53. JIN Y, Kim SC, Kim HJ, Ju W, et al
    Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer.
    Oncotarget. 2017;8:105425-105439.
    PubMed     Text format     Abstract available

  54. HAUGE A, Wegner CS, Gaustad JV, Simonsen TG, et al
    Diffusion-weighted MRI-derived ADC values reflect collagen I content in PDX models of uterine cervical cancer.
    Oncotarget. 2017;8:105682-105691.
    PubMed     Text format     Abstract available

  55. VATTAI A, Cavailles V, Sixou S, Beyer S, et al
    Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer.
    Oncotarget. 2017;8:105356-105371.
    PubMed     Text format     Abstract available


    Papillomavirus Res

  56. EHRENPREIS ED, Smith DG
    Patients with newly diagnosed cervical cancer should be screened for anal human papilloma virus and anal dysplasia: Results of a pilot study using a STELLA computer simulation and economic model.
    Papillomavirus Res. 2017;5:38-45.
    PubMed     Text format     Abstract available


    PLoS One

  57. ANDERSSON S, Belkic K, Demirbuker SS, Mints M, et al
    Perceived cervical cancer risk among women treated for high-grade cervical intraepithelial neoplasia: The importance of specific knowledge.
    PLoS One. 2017;12:e0190156.
    PubMed     Text format     Abstract available


  58. Correction: Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0190661.
    PubMed     Text format     Abstract available

  59. DA SILVA ERP, de Souza AS, de Souza TGB, Tsuha DH, et al
    Screening for cervical cancer in imprisoned women in Brazil.
    PLoS One. 2017;12:e0187873.
    PubMed     Text format     Abstract available


    Prev Med

  60. CASTANON A, Sasieni P
    Is the recent increase in cervical cancer in women aged 20-24years in England a cause for concern?
    Prev Med. 2017;107:21-28.
    PubMed     Text format     Abstract available


    Psychooncology

  61. FIELDING S, Rothnie K, Gray NM, Little J, et al
    Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial.
    Psychooncology. 2017;26:476-483.
    PubMed     Text format     Abstract available

  62. CHORLEY AJ, Marlow LA, Forster AS, Haddrell JB, et al
    Experiences of cervical screening and barriers to participation in the context of an organised programme: a systematic review and thematic synthesis.
    Psychooncology. 2017;26:161-172.
    PubMed     Text format     Abstract available


    Radiat Oncol

  63. CIHORIC N, Tsikkinis A, Vlaskou Badra E, Glatzer M, et al
    Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study.
    Radiat Oncol. 2017;12:202.
    PubMed     Text format     Abstract available


    Radiat Oncol J

  64. OH J, Seol KH, Lee HJ, Choi YS, et al
    Prophylactic extended-field irradiation with concurrent chemotherapy for pelvic lymph node-positive cervical cancer.
    Radiat Oncol J. 2017 Dec 23. pii: roj.2017.00367. doi: 10.3857/roj.2017.00367.
    PubMed     Text format     Abstract available


    Rev Epidemiol Sante Publique

  65. BOU-ORM IR, Sakr RE, Adib SM
    Cervical cancer screening among Lebanese women.
    Rev Epidemiol Sante Publique. 2017 Dec 14. pii: S0398-7620(17)30526.
    PubMed     Text format     Abstract available


    Sensors (Basel)

  66. ILIYASU AM, Fatichah C
    A Quantum Hybrid PSO Combined with Fuzzy k-NN Approach to Feature Selection and Cell Classification in Cervical Cancer Detection.
    Sensors (Basel). 2017;17.
    PubMed     Text format     Abstract available


    Signal Transduct Target Ther

  67. YANG X, Cheng Y, Li C
    The role of TLRs in cervical cancer with HPV infection: a review.
    Signal Transduct Target Ther. 2017;2:17055.
    PubMed     Text format     Abstract available


    Soc Sci Med

  68. KANGMENNAANG J, Onyango EO, Luginaah I, Elliott SJ, et al
    The next Sub Saharan African epidemic? A case study of the determinants of cervical cancer knowledge and screening in Kenya.
    Soc Sci Med. 2017;197:203-212.
    PubMed     Text format     Abstract available


    Tidsskr Nor Laegeforen

  69. TROPE A, Engesaeter B, Nygard M, Andreassen T, et al

    Tidsskr Nor Laegeforen. 2017;137.
    PubMed     Text format    


    Virus Res

  70. CHRISTENSEN ND, Budgeon LR, Cladel NM, Hu J, et al
    Recent advances in preclinical model systems for papillomaviruses.
    Virus Res. 2017;231:108-118.
    PubMed     Text format     Abstract available

  71. SCHELLENBACHER C, Roden RB, Kirnbauer R
    Developments in L2-based Human Papillomavirus (HPV) Vaccines.
    Virus Res. 2016 Nov 23. pii: S0168-1702(16)30528.
    PubMed     Text format     Abstract available

  72. YANG A, Farmer E, Lin J, Wu TC, et al
    The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
    Virus Res. 2016 Dec 5. pii: S0168-1702(16)30556.
    PubMed     Text format     Abstract available

  73. FILHO SMA, Bertoni N, Brant AC, Vidal JPCB, et al
    Methylation at 3'LCR of HPV16 can be affected by patient age and disruption of E1 or E2 genes.
    Virus Res. 2017;232:48-53.
    PubMed     Text format     Abstract available


    Viruses

  74. GRAVITT PE, Winer RL
    Natural History of HPV Infection across the Lifespan: Role of Viral Latency.
    Viruses. 2017;9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: